Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Background of Endothelial Cell Loss in Patients With Phakic Intraocular Lenses (MoBack-ECL): a Tear and Aqueous Humour Analysis Study

NCT04174924 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT04174924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04174924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Background of Endothelial Cell Loss in Patients With Phakic Intraocular Lenses (MoBack-ECL): a Tear and Aqueous Humour Analysis Study
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
July 2, 2020
Completion date
May 1, 2025
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract, phakic intraocular lens explantation